Lepu Biopharma Co., Ltd. (2157.HK)
2157.HK Stock Price Chart
Explore Lepu Biopharma Co., Ltd. interactive price chart. Choose custom timeframes to analyze 2157.HK price movements and trends.
2157.HK Company Profile
Discover essential business fundamentals and corporate details for Lepu Biopharma Co., Ltd. (2157.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
23 Feb 2022
Employees
498.00
Website
https://www.lepubiopharma.comCEO
Ziye Sui
Description
Lepu Biopharma Co., Ltd., a biopharmaceutical company, focuses on developing oncology therapeutics with a pipeline designed with a range of oncology products in China. The company develops oncology drug candidates, including antibody-drug conjugates (ADC), oncolytic virus drugs, and immunotherapies. It develops immuno-oncology products, such as HX008 Anti-PD-1 mAb and LP002 Anti-PD-L1 mAb; ADC products, including MRG003 EGFR-targeted ADC, MRG002 HER2-targeted ADC, MRG001 CD20-targeted ADC, MRG004A TF-targeted ADC, and CMG901 CLDNI8.2-targeted ADC; CG0070 oncolytic virus; and other drug candidates, such as HX008+OH2, LP002+OH2, and HX008+LP002. The company was incorporated in 2018 and is headquartered in Shanghai, China.
2157.HK Financial Timeline
Browse a chronological timeline of Lepu Biopharma Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 31 Dec 2024
EPS came in at -$0.07 , while revenue for the quarter reached $124.74M .
Earnings released on 30 Sept 2024
EPS came in at -$0.07 , while revenue for the quarter reached $129.75M .
Earnings released on 21 Aug 2024
EPS came in at -$0.06 , while revenue for the quarter reached $71.53M .
Earnings released on 14 Jun 2024
EPS came in at -$0.06 , while revenue for the quarter reached $72.17M .
Earnings released on 28 Mar 2024
EPS came in at $0.08 , while revenue for the quarter reached $77.74M .
Earnings released on 31 Jan 2024
EPS came in at $0.04 , while revenue for the quarter reached $38.40M .
Earnings released on 25 Aug 2023
EPS came in at -$0.10 , while revenue for the quarter reached $173.51M .
Earnings released on 26 Apr 2023
EPS came in at -$0.05 , while revenue for the quarter reached $87.68M .
Earnings released on 17 Mar 2023
Earnings released on 31 Dec 2022
EPS came in at -$0.23 , while revenue for the quarter reached $17.47M .
Earnings released on 25 Aug 2022
EPS came in at -$0.25 .
Earnings released on 30 Jun 2022
EPS came in at -$0.26 .
Earnings released on 10 Mar 2022
Earnings released on 29 Jun 2021
EPS came in at -$0.37 .
2157.HK Stock Performance
Access detailed 2157.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.